Truqap is a kinase inhibitor that works by blocking pathways that assist the most cancers cells endure and improve, so reduces cancer development. Truqap is from a class of medicines identified as an AKT inhibitor. Truqap received FDA acceptance on November seventeen, 2023, immediately after favourable results from the CAPItello-291 https://peterz221nyi4.azuria-wiki.com/user